Clinical Trial Update: Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Saccharomyces boulardii for preventing necrotizing enterocolitis in very low birth weight infants. The current status of the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Necrotizing Enterocolitis, Very Low Birth Weight Infants | Phase 3 | Status: UNKNOWN